Now available PEMFEXY™ (pemetrexed injection)

PEMFEXY ™ (pemetrexed injection) is a folate analog metabolic inhibitor indicated for:

• in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic non-squamous, non-small cell lung cancer (NSCLC). (1.1)


• as a single agent for the maintenance treatment of patients with locally advanced or metastatic non-squamous NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. (1.1)


• as a single agent for the treatment of patients with recurrent, metastatic non-squamous NSCLC after prior chemotherapy. (1.1) Limitations of Use: PEMFEXY is not indicated for the treatment of patients with squamous cell non-small cell lung cancer. (1.1)


• in combination with cisplatin for the initial treatment, of patients with malignant pleural mesothelioma whose disease is unresectable or who are otherwise not candidates for curative surgery. (1.2)